Exchange Traded Concepts’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Exchange Traded Concepts's BIO Position: Q3 2026 in Review
Exchange Traded Concepts increased its Bio-Rad Laboratories Class A (BIO) stake by 22% in Q3 2026, buying an estimated $5.44M and bringing the position to 87,691 shares worth $33.1M. The position accounts for 0.13% of the portfolio, ranked #138.
Exchange Traded Concepts first reported a position in BIO in Q4 2019 and has held it in 28 quarters since. 419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Exchange Traded Concepts held 87,691 shares of Bio-Rad Laboratories Class A worth $33.1M as of Q3 2026.
- Exchange Traded Concepts bought 15,575 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $5.44M.
- Bio-Rad Laboratories Class A made up 0.13% of Exchange Traded Concepts's portfolio in Q3 2026, its #138 holding.
- Exchange Traded Concepts first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 28 quarters since.
- 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Exchange Traded Concepts's 13F filing for Q3 2026, filed 28 Oct 2026.